Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL2457320

N.c1cc2cc(c1)CC2

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1760719 0.96 NR1H2 (0.34)
SCHEMBL25365911 0.96 NR1H2 (0.34)
Ammonia Solution, Strong SCHEMBL6823706 0.87 TSHR (0.32)
Dimethylamine SCHEMBL29203962 0.84 ACHE (0.32)
SCHEMBL14811593 0.83
SCHEMBL27603876 0.82 CCNB2 (0.31)
SCHEMBL31557612 0.80 TSHR (0.38)
SCHEMBL31557611 0.80 TSHR (0.38)
SCHEMBL24524284 0.80 CYP3A4 (0.41)
SCHEMBL27608982 0.76 NR1H2 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200332043-A1 A QUADRIPOLYMER BASED ON HOST-GUEST INTERACTION AND PREPARATION PROCESS THEREOF SOUTHWEST PETROLEUM UNIVERSITY (CN) 2020-10-22 US claimed
CN-110392940-B Solar cell and method for manufacturing same 积水化学工业株式会社 2023-04-28 CN disclosed
CN-111841515-B Ionic liquid bridged hybrid silicon oxide as water-rich chromatographic stationary phase and preparation method and application thereof 镇江海关综合技术中心 2023-03-28 CN disclosed
CN-111841515-A Ionic liquid bridged hybrid silicon oxide as water-rich chromatographic stationary phase and preparation method and application thereof 镇江海关综合技术中心 2020-10-30 CN disclosed
US-20200199485-A1 GREASE COMPOSITIONS HAVING POLYUREA THICKENERS MADE WITH ISOCYANATE TERMINATED PREPOLYMERS EXXONMOBIL RES & ENG CO (US) 2020-06-25 US disclosed
WO-2018188990-A1 BIOTIN-CONJUGATED N-ACETYL GLYCOL SPLIT HEPARIN LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE (CH) 2018-10-18 WO disclosed
EP-3388419-A1 GLI1 INHIBITORS AND USES THEREOF Leadiant Biosciences SA (CH) 2018-10-17 EP disclosed
EP-3388439-A1 BIOTIN-CONJUGATED N-ACETYL GLYCOL SPLIT HEPARIN Leadiant Biosciences SA (CH) 2018-10-17 EP disclosed
WO-2018177860-A1 2-(4-(4-(BROMO-METHOXYBENZAMIDO)BENZYLAMINO)PHENYL)BENZAZOLE DERIVATIVES AND THEIR USE AS ANTI-HEPARANASE LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE (CH) 2018-10-04 WO disclosed
WO-2018177863-A1 DERIVATIVES OF THE DISODIUM 2,2'-{CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(1-METHYL-1H-PYRROLE-4,2-DIYL) CARBONYLIMINO]}DINAPHTHALENE-1,5-DISULFONATE SALT AND RELATED COMPOUNDS AS HEPARANASE INHIBITORS FOR THE TREATMENT OF CANCER LEADIANT BIOSCIENCES SA IN LIQUIDAZIONE (CH) 2018-10-04 WO disclosed
US-5728717-A COGNITION ACTIVATORS, ANTIDEPRESSANTS HOECHST MARION ROUSSEL INC. (US) 1998-03-17 US disclosed
US-5668154-A TREATMENT OF MEMORY DYSFUNCTION, ALZHEIMER*S DISEASE, ANTIDEPRESSANTS HOECHST MARION ROUSSEL INC. (US) 1997-09-16 US disclosed
WO-1996039405-A1 PYRIDINIMINYL-1,2-BENZISOXAZOLES AND- BENZISOTHIAZOLES AS ANTIPSYCHOTIC AGENTS HOECHST MARION ROUSSEL, INC. (US) 1996-12-12 WO disclosed
EP-0717638-A1 IMPROVED PHARMACEUTICAL FORMULATION SUPERGEN, INC. (US) 1996-06-26 EP disclosed
US-5494908-A ANTIDEPRESSANT HOECHST-ROUSSEL PHARMACEUTICAL INCORPORATED (US) 1996-02-27 US disclosed
WO-1995006485-A1 IMPROVED PHARMACEUTICAL FORMULATION SUPERGEN, INC. (US) 1995-03-09 WO disclosed
EP-0586585-A4 1994-08-31 EP disclosed
EP-0583161-A2 4-Aminopyrrole-2-carboxamide derivatives as antiviral agents PHARMACIA S.p.A. (IT) 1994-02-16 EP disclosed
EP-0550518-A1 1-SUBSTITUTED PHENOXATHIIN DERIVATIVES AS ANTIDEPRESSANTS THE WELLCOME FOUNDATION LIMITED (GB) 1993-07-14 EP disclosed
WO-1988002370-A1 2-SUBSTITUTED-E-FUSED-[1,2,4]TRIAZOLO[1,5-C]PYRIMIDINES PHARMACEUTICAL COMPOSITIONS AND USES THEREOF CIBA-GEIGY AG (CH) 1988-04-07 WO disclosed